Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Current Trends in Antibody Drug Conjugates

Jeremy Parker's Biography



Jeremy Parker, Project Leader

Dr. Jeremy Parker obtained his BSc in Chemistry from Imperial College, University of London in 1994. He then moved to the University of Oxford, completing a DPhil investigating biomimetic Diels-Alder reactions with Professor Sir J E Baldwin. He joined AstraZeneca in 1999 and has held various roles including Technical Sourcing Manager, Analytical Chemistry Team Manager and Process Chemistry Team Manager. In 2013 he took over responsibility for all Antibody Drug Conjugate Payload projects within AstraZeneca, and is currently a Principal Scientist, based at Macclesfield in the United Kingdom.

Jeremy Parker Image